Unravelling the role of denosumab in prostate cancer
- PMID: 21353698
- DOI: 10.1016/S0140-6736(11)60100-1
Unravelling the role of denosumab in prostate cancer
Comment on
-
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.Lancet. 2011 Mar 5;377(9768):813-22. doi: 10.1016/S0140-6736(10)62344-6. Epub 2011 Feb 25. Lancet. 2011. PMID: 21353695 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical